Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Oral famotidine versus placebo in non-hospitalised patients with COVID-19: a randomised, double-blind, data-intense, phase 2 clinical trial
Christina Brennan, Sandeep Nadella, Xiang Zhao, et al.
Gut (2022) Vol. 71, Iss. 5, pp. 879-888
Open Access | Times Cited: 36

Showing 1-25 of 36 citing articles:

Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients With COVID-19 (September 2022)
Adarsh Bhimraj, Rebecca L. Morgan, Amy Hirsch Shumaker, et al.
Clinical Infectious Diseases (2022) Vol. 78, Iss. 7, pp. e250-e349
Open Access | Times Cited: 120
COVID-19 therapeutics: Small-molecule drug development targeting SARS-CoV-2 main protease
Thales Kronenberger, Stefan Laufer, Thanigaimalai Pillaiyar
Drug Discovery Today (2023) Vol. 28, Iss. 6, pp. 103579-103579
Open Access | Times Cited: 40
Signaling pathways in macrophages: molecular mechanisms and therapeutic targets
Ming Li, Mengjie Wang, Yuanjia Wen, et al.
MedComm (2023) Vol. 4, Iss. 5
Open Access | Times Cited: 40
Postacute Sequelae of SARS-CoV-2 in Children
Suchitra Rao, Rachel S. Gross, Sindhu Mohandas, et al.
PEDIATRICS (2024) Vol. 153, Iss. 3
Closed Access | Times Cited: 34
Impact of COVID-19 on the liver and on the care of patients with chronic liver disease, hepatobiliary cancer, and liver transplantation: An updated EASL position paper
Thomas Marjot, Christiane S. Eberhardt, Tobias Boettler, et al.
Journal of Hepatology (2022) Vol. 77, Iss. 4, pp. 1161-1197
Open Access | Times Cited: 62
Long COVID: Clinical characteristics, proposed pathogenesis and potential therapeutic targets
Grace Kenny, Liam Townsend, Stefano Savinelli, et al.
Frontiers in Molecular Biosciences (2023) Vol. 10
Open Access | Times Cited: 34
Antiviral Therapy of COVID-19
Georgii Gudima, И.А. Кофиади, I.P. Shilovskiy, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 10, pp. 8867-8867
Open Access | Times Cited: 24
Lots of long COVID treatment leads, but few are proven
L. H. Shaffer
Proceedings of the National Academy of Sciences (2022) Vol. 119, Iss. 36
Open Access | Times Cited: 20
No evidence of clinical efficacy of famotidine for the treatment of COVID-19: a systematic review and meta-analysis
Huzaifa Ahmad Cheema, Arman Shafiee, Mohammad Mobin Teymouri Athar, et al.
Journal of Infection (2022) Vol. 86, Iss. 2, pp. 154-225
Open Access | Times Cited: 19
SARS-CoV-2 replication and drug discovery
Farah Nazir, Arnaud John Kombe Kombe, Zunera Khalid, et al.
Molecular and Cellular Probes (2024) Vol. 77, pp. 101973-101973
Open Access | Times Cited: 3
Effect of famotidine on cognitive and behavioral dysfunctions induced in post-COVID-19 infection: A randomized, double-blind, and placebo-controlled study
Sara Momtazmanesh, Sahar Ansari, Zahra Izadi, et al.
Journal of Psychosomatic Research (2023) Vol. 172, pp. 111389-111389
Open Access | Times Cited: 9
Famotidine activates the vagus nerve inflammatory reflex to attenuate cytokine storm
Huan Yang, Sam J. George, Dane Thompson, et al.
Molecular Medicine (2022) Vol. 28, Iss. 1
Open Access | Times Cited: 15
Network-based drug repurposing for the treatment of COVID-19 patients in different clinical stages
Xin Wang, Han Wang, Guosheng Yin, et al.
Heliyon (2023) Vol. 9, Iss. 3, pp. e14059-e14059
Open Access | Times Cited: 7
Using digital tools in clinical, health and social care research: a mixed-methods study of UK stakeholders
Sophie Clohessy, Theodoros N. Arvanitis, Umer Rashid, et al.
BMJ Open (2024) Vol. 14, Iss. 4, pp. e076613-e076613
Open Access | Times Cited: 2
Vagus nerve SARS‐CoV‐2 infection and inflammatory reflex dysfunction: Is there a causal relationship?
Jan Andersson, Kevin J. Tracey
Journal of Internal Medicine (2023) Vol. 295, Iss. 1, pp. 91-102
Open Access | Times Cited: 5
SARS-CoV-2 spike protein-ACE2 interaction increases carbohydrate sulfotransferases and reduces N-acetylgalactosamine-4-sulfatase by p38 MAPK
Sumit Bhattacharyya, Joanne K. Tobacman
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 1
Proton pump inhibitors and risk of severe COVID-19 in older people
Baptiste Gramont, Sophie Fayolle, Divà Beltramin, et al.
Age and Ageing (2024) Vol. 53, Iss. 4
Closed Access | Times Cited: 1
Infectious Diseases
Herman Li, Niccolò Terrando, Harris A. Gelbard
Advances in neurobiology (2024), pp. 423-444
Closed Access | Times Cited: 1
Use of proton pump inhibitors and risk of severe COVID‐19: A case–control study in United States Medicare beneficiaries
Andrew D. Mosholder, Héctor S. Izurieta, Rongmei Zhang, et al.
Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy (2024) Vol. 44, Iss. 10, pp. 803-810
Open Access | Times Cited: 1
Lessons Learned From Clinical Trials of Immunotherapeutics for COVID‐19
Ickjai Lee, Christopher Lupfer
Immunological Reviews (2024)
Closed Access | Times Cited: 1
Drug development process and COVID-19 pandemic
Himika Wasan, Devendra Singh, K.H. Reeta, et al.
Indian Journal of Pharmacology (2022) Vol. 54, Iss. 5, pp. 364-372
Open Access | Times Cited: 5
Effectiveness of famotidine on the risk of poor prognosis in patients with COVID-19: A nationwide cohort study in Korea
Rosie Kwon, Hyung‐Jun Kim, Seung Won Lee, et al.
Heliyon (2023) Vol. 9, Iss. 6, pp. e16171-e16171
Open Access | Times Cited: 2
A retrospective analysis of clinical outcomes between hospitalized patients with COVID‐19 who received famotidine or pantoprazole
Justin Wagner, Nikolas St. Cyr, Aaron Douen, et al.
JGH Open (2023) Vol. 7, Iss. 7, pp. 464-469
Open Access | Times Cited: 2
Targeting of KOR by famotidine promotes OPC maturation differentiation and CNS remyelination via STAT3 signaling pathway
Mingyue Bao, Chen-Yu Feng, Xiu‐Qing Li, et al.
International Journal of Biological Macromolecules (2024) Vol. 269, pp. 131964-131964
Closed Access
Famotidina en el tratamiento de pacientes hospitalizados con COVID-19. Revisión sistemática y metaanálisis
John S. Paisig Rosas, Alex N. Castañeda Sabogal
Revista chilena de infectología (2024) Vol. 41, Iss. 1, pp. 7-19
Open Access
Page 1 - Next Page

Scroll to top